Ohio State treats Midwest’s first patient in a trial of novel ventricular tachycardia device

The Medical News ·
Health & Medicine United Kingdom

The Ohio State University Wexner Medical Center is the first center in the Midwest to enroll and treat a patient in a new clinical trial using a novel device designed to treat recurrent ventricular tachycardia (VT), a serious heart rhythm disorder.

Read original article on The Medical News →

Related news